JAZZ LongStrong financials and earnings growth appears to have bottomed out and is now on the trend up. Healthcare can also be a hedge against inflation, which has a serious chance of reemerging, especially if rates were to pause.
Key stats
About Jazz Pharmaceuticals plc
Sector
CEO
Bruce C. Cozadd
Headquarters
Dublin
Website
Founded
2005
ISIN
BRJ2AZBDR009
FIGI
BBG014XJG8K5
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
